信达生物(01801) - 2025 H2 - 电话会议演示

Innovent Biologics 2025 Annual Results From China Leadership to Global Premier: Innovent's Definitive Path to Value and Growth March 2026 Agenda and Speakers | Business Review and Outlook | Dr. Michael Yu | Founder, Chairman of the Board, CEO | | --- | --- | --- | | R&D Highlight Updates | Dr. Hui Zhou | Chief R&D Officer, Oncology | | | Dr. Lei Qian | Chief R&D Officer, General Biomedicine | | Financials and Summary | Ms. Rachel You | Chief Financial Officer | | Q&A | Management Team | | Confidential Copyr ...